DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage

Oncolytic virotherapy is a promising therapeutic strategy that uses replication-competent viruses to selectively destroy malignancies. However, the therapeutic effect of certain oncolytic viruses (OVs) varies among cancer patients. Thus, it is necessary to overcome resistance to OVs through rational...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nat Commun
Asıl Yazarlar: Xiao, Xiao, Liang, Jiankai, Huang, Chunlong, Li, Kai, Xing, Fan, Zhu, Wenbo, Lin, Ziqing, Xu, Wencang, Wu, Guangen, Zhang, Jifu, Lin, Xi, Tan, Yaqian, Cai, Jing, Hu, Jun, Chen, Xueqin, Huang, Youwei, Qin, Zixi, Qiu, Pengxin, Su, Xingwen, Chen, Lijun, Lin, Yuan, Zhang, Haipeng, Yan, Guangmei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6194050/
https://ncbi.nlm.nih.gov/pubmed/30337542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-06771-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller